Realcan Pharmaceutical Group Co (SZSE:002589) Scaled Net Operating Assets : 0.40 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Realcan Pharmaceutical Group Co's operating assets for the quarter that ended in Mar. 2024 was ¥11,536 Mil. Realcan Pharmaceutical Group Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥4,818 Mil. Realcan Pharmaceutical Group Co's Total Assets for the quarter that ended in Dec. 2023 was ¥16,709 Mil. Therefore, Realcan Pharmaceutical Group Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.40.

Realcan Pharmaceutical Group Co Scaled Net Operating Assets Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Scaled Net Operating Assets Chart

Realcan Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.34

0.44

0.29

0.16

0.40

Realcan Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.24	0.20	0.22	0.43	0.40

Competitive Comparison of Realcan Pharmaceutical Group Co's Scaled Net Operating Assets

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Realcan Pharmaceutical Group Co's Scaled Net Operating Assets Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Scaled Net Operating Assets falls into.

Realcan Pharmaceutical Group Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Realcan Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(11648.519	-	4248.034)	/	18332.213
=	0.40

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	16709.306	-	5060.787
=	11648.519

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	11072.329	-	262.11	-	6562.185
=	4248.034

Realcan Pharmaceutical Group Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(11536.184	-	4817.97)	/	16709.306
=	0.40

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	15558.94	-	4022.756
=	11536.184

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	9903.392	-	274.143	-	4811.279
=	4817.97

Realcan Pharmaceutical Group Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004

Website

http://www.realcan.cn

Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines